SEARCH

SEARCH BY CITATION

References

  • 1
    Malafosse R,Penna C,Sa Cunha A,Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 88794.
  • 2
    Fiorentini G,Poddie DB,Cantore M.,Giovanis P,Guadagni S,DeGiorgi U,Cariallo A,Dazzi C,Turci D. Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepato-Gastroenterology 2001; 48: 30512.
  • 3
    Bentrem DJ,Dematteo RP,Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005; 56: 13956.
  • 4
    Ruan DT,Warren RS. Liver-directed therapies in colorectal cancer. Semin Oncol 2005; 32: 8594.
  • 5
    Salem R,Thurston KG. Radioembolization with Yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, Part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006; 17: 157194.
  • 6
    Soloway AH,Hatanaka H,Davis MA. Penetration of brain and brain tumor. VII. Tumor binding sulfhydryl boron compounds. J Med Chem 1967; 10: 71417.
  • 7
    Kageji T,Nagahiro S,Mizobuchi Y,Toi H,Nakagawa Y,Kumada H. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome. Int J Radiat Oncol Biol Phys 2006; 65: 144655.
  • 8
    Hatanaka H. A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments. J Neurol 1975; 209: 8194.
  • 9
    Sauerwein W,Zurlo A. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future perspectives. Eur J Cancer 2002; 38: S31S34.
  • 10
    Sauerwein W,Hideghéty K,Gabel D,Moss RL. European clinical trials of boron neutron capture therapy for glioblastoma. Nuclear News 1998; 41: 546.
  • 11
    Wittig A,Moss RL,Stecher-Rasmussen F,Appelman K,Rassow J,Roca A,Sauerwein W. Neutron Activation of Patients Following Boron Neutron Capture Therapy of Brain Tumors at the High Flux Reactor (HFR) Petten (EORTC Trials 11961 and 11011). Strahlenther Onkol 2005; 181: 77482.
  • 12
    Snyder HR,Reedy AJ,Lennarj WJ. Synthesis of aromatic boronic acids. Aldehyde boronic acids and a boronic acid analog of tyrosine. J Am Chem Soc 1958; 80: 8358.
  • 13
    Kiger WS,Palmer MR,Riley KJ,Zamenhof RG,Busse PM. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans. Radiat Res 2001; 155: 61118.
  • 14
    Busse PM,Harling OK,Palmer MR,Kiger WS,III,Kaplan J,Kaplan I,Chuang CF,Goorley JT,Riley KJ,Newton TH,Santa Cruz GA,Lu XQ, et al. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 2003; 62: 11121.
  • 15
    Bergenheim AT,Capala J,Roslin M,Henriksson R. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol 2005; 71: 28793.
  • 16
    Kato I,Ono K,Sakurai Y,Ohmae M,Maruhashi A,Imahori Y,Kirihata M,Nakazawa M,Yura Y. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 2004; 61: 106973.
  • 17
    Aihara T,Hiratsuka J,Morita N,Uno M,Sakurai Y,Maruhashi A,Ono K,Harada T. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck 2006; 28: 8505.
  • 18
    Nano R,Barni S,Chiari P,Pinelli T,Fossati F,Altieri S,Zonta C,Prati U,Roveda L,Zonta A. Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma: optical and ultrastructural study in the rat. Oncol Rep 2004; 11: 14953.
  • 19
    Nano R,Barni S,Gerzeli G,Pinelli T,Altieri S,Fossati F,Prati U,Roveda L,Zonta A. Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases. Ann NY Acad Sci 1997; 832: 2748.
  • 20
    Roveda L,Prati U,Bakeine J,Trotta F,Marotta P,Valsecchi P,Zonta A,Nano R,Facoetti A,Chiari P,Barni S,Pinelli T, et al. How to study boron biodistribution in liver metastases from colorectal cancer. J Chemother 2004; 16 ( Suppl 5): 1518.
  • 21
    Chiaraviglio D,De Grazia F,Zonta A,Altieri S,Braghieri A,Fossati F,Pedroni P,Pinelli T,Perotti A,Specchariello M,Perlini G,Rief H. Evaluation of selective boron absorption in liver tumors. Strahlenther Onkol 1989; 1989: 1702.
  • 22
    Pinelli T,Zonta A.Altieri S,Barni S,Braghieri A,Pedroni P,Bruschi P,Chiari P,Ferrari C,Fossati F,Nano R,Ngnitejeu Tata S,Prati U,Ricevuti G,Roveda L,Zonta C. TAOrMINA: from the first idea to the application to the human liver. In: SauerweinW,MossR,WittigA, editors. Research and development in neutron capture therapy. Bologna: Munduzzi Editore, 2002.
  • 23
    Nievaart V,Wittig A,Moss R,Rassow J,Sauerwein W. Optimisation of treatment planning for multi-beam Boron Neutron Capture Therapy (BNCT) using epithermal neutron beams in patients with multiple metastases to the brain from malignant melanoma. Strahlenther Onkol 2006; 182: 109.
  • 24
    Dawson LA,Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005; 15: 27983.
  • 25
    Ono K,Masunaga SI,Kinashi Y,Takagaki M,Akaboshi M,Kobayashi T,Akuta K. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996; 34: 10816.
  • 26
    Ono K,Masunaga S-I,Suzuki M,Kinashi Y,Takagaki M,Akaboshi M. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice. Int J Radiat Oncol Biol Phys 1999; 43: 4316.
  • 27
    Coderre JA,Chanana AD,Joel DD,Elowitz EH,Micca PL,Nawrocky MM,Chadha M,Gebbers JO,Shady M,Peress NS,Slatkin DN. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res 1998; 149: 16370.
  • 28
    van Rij CM,Sinjewel A,van Loenen AC,Sauerwein WA,Wittig A,Kriz O,Wilhelm AJ. Stability of 10B-L-boronophenylalanine-fructose injection. Am J Health Syst Pharm 2005; 62: 260810.
  • 29
    Raaijmakers CPJ,Konijnenberg MW,Dewit L,Haritz D,Huiskamp R,Siefert A,Stecher-Rasmussen F,Mijnheer BJ. Monitoring of blood-10B concentration for boron neutron capture therapy using prompt gamma-ray analysis. Acta Oncol 1995; 34: 51724.
  • 30
    Thellier M,Chevallier A,His I,Jarvis MC,Lovell MA,Ripoll C,Robertson D,Sauerwein W,Verdus M-C. Methodological developments for application to the study of physiological boron and to boronneutron capture therapy. J Trace Microprobe Tech 2001; 19: 62357.
  • 31
    Kiger WS,III,Palmer MR,Riley KJ,Zamenhof RG,Busse PM. Pharmacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences. J Neurooncol 2003; 62: 17186.
  • 32
    Hideghéty K,Sauerwein W,Wittig A,Götz C,Paquis P,Grochulla F,Haselsberger K,Wolbers J,Moss R,Huiskamp R,Fankhauser H,de Vries M, et al. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial. J Neurooncol 2003; 62: 14556.
  • 33
    Kageji T,Nagahiro S,Kitamura K,Nakagawa Y,Hatanaka H,Haritz D,Grochulla F,Haselsberger K,Gabel D. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma. Int J Radiat Oncol Biol Phys 2001; 51: 12030.
  • 34
    Kageji T,Otersen B,Gabel D,Huiskamp R,Nakagawa Y,Matsumoto K. Interaction of mercaptoundecahydrododecaborate (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy. Biochim Biophys Acta 1998; 1391: 37783.
  • 35
    Yoshida F,Matsumura A,Yamamoto T,Kumada H,Nakai K. Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect. Cancer Lett 2004; 215: 617.
  • 36
    Trivillin VA,Heber EM,Nigg DW,Itoiz ME,Calzetta O,Blaumann H,Longhino J,Schwint A. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res 2006; 166: 38796.
  • 37
    Liberman SJ,Dagrosa A,Jimenez Rebagliati RA,Bonomi MR,Roth BM,Turjanski L,Castiglia SI,Gonzalez SJ,Menendez PR,Cabrini R,Roberti MJ,Batistoni DA. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina. Appl Radiat Isot 2004; 61: 1095100.
  • 38
    Coderre JA,Elowitz EH,Chadha M,Bergland R,Capala J,Joel DD,Liu HB,Slatkin DN,Chanana AD. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J Neurooncol 1997; 33: 14152.
  • 39
    Chadha M,Capala J,Coderre JA,Elowitz EH,Iwai J,Joel DD,Liu HB,Wielopolski L,Chanana AD. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys 1998; 40: 82934.
  • 40
    Coderre JA,Glass JD,Fairchild RG,Roy U,Cohen S,Fand I. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res 1987; 47: 637783.
  • 41
    Wittig A,Sauerwein WA,Coderre JA. Mechanisms of transport of p-Borono-phenylalanine through the cell membrane in vitro. Radiat Res 2000; 153: 17380.
  • 42
    Tsukada H,Kengo S,Fukumoto D,Nishiyama S,Harada N,Kakiuchi T. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine J Nucl Med 2006; 47: 67988.
  • 43
    Ishiwata Kawamura K,Wang WF,Furumoto S,Kubota K,Pascali C,Bogni A,Iwata R. Evaluation of O-[11C]methyl-Ltyrosine and O-[18F]fluoromethyl-L-tyrosine as tumor imaging tracers by PET. Nucl Med Biol 2004; 31: 1918.
  • 44
    Yanagida O,Kanai Y,Chairoungdua. A. Human L-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumour cell lines. Biochim Biophys Acta 2001; 1514: 291302.
  • 45
    Jager PL,Vaalburg W,Pruim J. Radiolabelled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001; 42: 43245.
  • 46
    Dagrosa MA,Viaggi M,Rebagliati RJ,Castillo VA,Batistoni D,Cabrini RL,Castiglia S,Juvenal GJ,Pisarev MA. Biodistribution of p-boronophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC). Appl Radiat Isot 2004; 61: 91115.
  • 47
    Pisarev MA,Dagrosa MA,Juvenal GJ. Application of boron neutron capture therapy to the treatment of anaplastic thyroid carcinoma: current status and future perspectives. Curr Opin Endocrinol Diabetes 2005; 12: 3525.
  • 48
    Pignol JP,Oudart H,Chauvel P,Sauerwein W,Gabel D,Prevot G. Selective delivery of 10B to soft tissue sarcoma using 10B-L-borophenylalanine for boron neutron capture therapy. Br J Radiol 1998; 71: 3203.